Program in Biotechnology Management and Entrepreneurship
This fall, Yeshiva University’s Katz School introduced a new 36-credit Master of Science in Biotechnology Management and Entrepreneurship (BME) designed to prepare entrepreneurs in the life sciences to successfully navigate the complex process of launching new medical drugs and devices into the marketplace.
The curriculum includes advanced topics in pharmacology, biologics, biodevices, clinical trials, biostatistics, and analytics along with finance, marketing, intellectual property law, and new business development. Students also have the opportunity to participate in industry-sponsored externships. The program has full-time and part-time on-campus classes, including in the evening.
Jeff Vockrodt and Brian Malkin of national law firm Arent Fox LLP with an office in New York City have joined the current Katz School faculty and advisory board as industry professors. Jeff Vockrodt, a registered patent attorney, advises companies on matters involving chemical and life science technologies. Brian Malkin is also a registered patent attorney and has more than two decades of experience in food and drug regulatory law as well as over 15 years intellectual property law for life science companies.
“Katz’s MS in Biotechnology Management and Entrepreneurship is a necessary educational program in New York City that will help train the next generation of biotechnology entrepreneurs seeking to bring new ideas from the bench to market to patients,” said Malkin. “I am teaching this course because I believe it is important for thought leaders in the life science industry to develop the next generation of talent. Our students are smart and hard working. I’m excited to help them consider New York City as their home base and to continue building the city’s emerging life sciences ecosystem.”
Dr. Rana Khan, founding director of the Biotechnology Management and Entrepreneurship Program at the Katz School, said, “this program fills a critical need in the biotechnology education arena to prepare high-value professionals and entrepreneurs. What sets it apart is an interdisciplinary curriculum that weaves in science with business and management and a project-based focus to develop entrepreneurial thinkers who can successfully navigate the complex process of commercializing new products and remedies.”
“This professional science master’s degree aligns closely with local market trends in the biotech startup community and with economic development initiatives, such as New York City’s LifeSciNY initiative, a $500 million investment to strengthen the biotech ecosystem in the city,” said Dr. Paul Russo, university vice provost and dean of the Katz School. “The program’s goal is to graduate students who have both a science background and an entrepreneurial mindset. Under the leadership of Dr. Kahn, BME students have the chance to work with faculty and industry advisors in Yeshiva University’s Innovation Lab to develop their own ideas for products through the early clinical stage and if possible, by launching their own startups.”